Stock Market Live 22/10 – Gilead Stock Climbs After FDA Approves Remdesivir

Sam Boughedda trader

Updated 22 Oct 2020

Open Demo Account YOUR CAPITAL IS AT RISK. 68% OF RETAIL CFD ACCOUNTS LOSE MONEY

Sam Boughedda trader

Sam is a trader and lead stock market writer at AskTraders. After starting his career in the forex market, Sam now focuses on stocks, specifically consumer staples.